Package Insert: Information for the Patient
Ebastina Sandoz 10 mg Film-Coated Tablets
Read this package insert carefully before starting to take this medication, as it contains important information for you.
Table of Contents:
Ebastina belongs to a group of medications called antihistamines (antiallergics).
Ebastina is indicated for the symptomatic treatment of allergic processes such as:
.
Do not take Ebastina Sandoz
Warnings and precautions
Consult your doctor or pharmacist before starting to take ebastina:
Do not use this medication if you have an acute allergic emergency, as ebastina (active ingredient of this medication) takes 1 to 3 hours to take effect.
Children
Ebastina should not be administered to children under 12 years.
Taking Ebastina Sandoz with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.
The medications listed below may interact with ebastina, in these cases it may be necessary to change the dose or discontinue treatment with one of them:
No interactions have been described between ebastina and theophylline, warfarin, cimetidine, diazepam, and alcohol.
Interference with diagnostic tests
Ebastina may interfere with the results of skin allergy tests, so it is recommended not to perform them until 5 to 7 days after discontinuing treatment.
Taking Ebastina Sandoz with food and drinks
This medication can be taken with or without food.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
There is no experience in pregnant women, so it is recommended to consult a doctor before taking ebastina. They will decide whether or not to start treatment.
Breastfeeding
It is unknown whether the medication passes into breast milk, so it should not be used during breastfeeding.
Driving and operating machinery
In men, no effects have been observed on psychomotor function, or on the ability to drive or operate machinery at the recommended therapeutic doses. However, given that drowsiness and dizziness are among the adverse effects, observe your response to the medication before driving or operating machinery.
Ebastina Sandoz contains lactose
This medication contains lactose. If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medication.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Remember to take your medication.
Your doctor will inform you of the duration of your treatment with ebastina.
Ebastina is not suitable for doses lower than 10 mg, nor for patients with swallowing problems.
Dosage
Use in adults and children over 12 years:The recommended dose is 1 tablet (10 mg of ebastina) once a day.
Use in patients with severe liver disease:Do not exceed a dose of 10 mg of ebastina per day (1 tablet).
Administration Form
This medication is for oral administration.
Tablets can be taken with or without food, with the help of a glass of water.
If you estimate that the action of ebastina is too strong or too weak, inform your doctor or pharmacist.
If you take more Ebastina Sandoz than you should
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.Bring the remaining tablets, the packaging, and the complete box in a way that healthcare personnel can easily identify the medication taken.
The treatment of intoxication by this medication consists of gastric lavage and administration of the appropriate medication.
If you forgot to take Ebastina Sandoz
Do not take a double dose to compensate for the missed doses. Take the missed dose when you remember and then continue with your regular schedule. However, if there are only a few hours left before the next dose, do not take the missed dose and wait for the next dose at the scheduled time.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may produce adverse effects, although not all people may experience them.
In clinical trials and post-marketing experience, the following adverse effects have been observed:
Very Frequent(may affect more than 1 in 10 people)
Frequent(may affect up to 1 in 10 people)
Rare(may affect up to 1 in 1,000 people)
Unknown Frequency(cannot be estimated from available data)
-Weight gain,
-Increased appetite.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly to theSpanish System for Pharmacovigilance of Medicinal Products for Human Use:https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date that appears on the box after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and unused medicines at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and unused medicines. By doing so, you will help protect the environment.
Ebastina Sandoz Composition
Core: lactose monohydrate, microcrystalline cellulose, pregelatinized cornstarch, povidone 30, polisorbate 80, magnesium stearate,
Coating: hypromellose, titanium dioxide, triacetin
Product appearance and packaging contents
Ebastina Sandoz is presented in the form of coated tablets with a white, lenticular film coating. It is packaged in PVC/Aluminum blisters containing 20 tablets of 10 mg.
Marketing authorization holder and manufacturer
Marketing authorization holder
Sandoz Farmacéutica, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Manufacturer
Laboratorios ALTER, S.A.
Mateo Inurria, 30
28036 Madrid
Spain
Last review date of this leaflet: May 2019.
The detailed information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.